Enlaye | $1,700,000 | (Oct 2, 2024)
Numa(US) | $32,000,000 | (Oct 2, 2024)
Hyivy Health | $2,000,000 | (Oct 2, 2024)
Mindpeak GmbH
Germany
- Hamburg
- 01/10/2024
- Series A
- $15,300,000
Mindpeak's mission is to enable personalised cancer treatment through AI tissue diagnostics
Our partners are leading pathology and university labs. Our team consists of world-class industry experts in machine learning and company building.
Mindpeak's Impact
The demand for medical image analysis is growing rapidly but the number of cancer experts remains the same - this results in growing workloads per specialist. We help cancer experts meet this challenge.
We build automation tools for visual diagnosis using state-of-the-art artificial intelligence and deep learning. Our tools assist cancer experts in providing reliable and reproducible diagnoses. This frees specialists from tedious, repetitive tasks such as quantification of cells or biomarkers and allows them to focus on tasks where their human expertise is indispensable.
If you want to get in touch with us send us an E-Mail via info@mindpeak.ai.
- Industry Information Technology & Services
- Website https://www.mindpeak.ai/
- LinkedIn https://www.linkedin.com/company/mindpeak-gmbh/
Indiegraf | $2,200,000 | (Oct 2, 2024)
Anaphite | $13,700,000 | (Oct 2, 2024)
LoQus23 Therapeutics Ltd | $46,550,175 | (Oct 2, 2024)
DocJuris | $8,000,000 | (Oct 2, 2024)
Nusano | $115,000,000 | (Oct 2, 2024)
Thread AI | $6,000,000 | (Oct 2, 2024)
syte | $5,559,650 | (Oct 1, 2024)
SETTLE PAYMENTS | $2,000,000 | (Oct 1, 2024)
Atlas Metrics | $13,557,579 | (Oct 1, 2024)